Close X
Attorney Spotlight

What emerging trend in shareholder litigation does Britt Latham find most interesting in his practice today?    Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Successful Defense of Various Clients in Extrapolated Overpayment Audit Appeals

Client Type: Public Company

We successfully defended a number of clients across industry sectors, including hospitals, physician practices, hospices, home health agencies and DMEPOS suppliers, in appealing audit results where statistical sampling was used to calculate to extrapolated overpayment demands. Through the Medicare claims appeal process, we have successfully argued that the statistical sampling methodology was invalid and should be set aside and have succeeded in obtaining favorable claims decisions on individual claims. Representative matters include:

  • We successfully defended a home health agency in appealing a $9.3 million extrapolated overpayment resulting from a ZPIC audit. Through the Medicare claims appeal process, we successfully argued that the statistical sampling methodology was invalid and should be set aside, resulting in the demand being reduced to under $175,000 before individual claims arguments were considered.
  • We are currently representing a home health agency in appealing an $18 million extrapolated overpayment demand resulting from a ZPIC audit. At the first appeal level, we were successful in reducing the overpayment demand to $8 million and are continuing to appeal the remaining claims denials.
  • We are currently representing a large, privately held hospice provider in the appeal of 12 ZPIC audits involving extrapolated overpayment demands totaling over $16 million. To date, we have been successful in overturning extrapolation in 7 of the audits at the first level of appeal and have reduced the error rate in all 12 audits, resulting in the overturning of over $9 million in overpayment demands.

You Also May Be Interested In:

Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.